U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07449507) titled 'Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy' on Feb. 27.
Brief Summary: This study is a prospective, multicenter, randomized controlled trial designed to evaluate the clinical efficacy, tolerance, and safety of a partially hydrolyzed whey protein formula in infants with mild allergic symptoms. Partially hydrolyzed formulas contain low-molecular weight peptides and have been shown to improve protein tolerance and digestibility and to reduce allergenicity compared with intact cow's milk protein formulas. However, evidence regarding their therapeutic effects in infants who have already developed allergic sym...